Global Institute Of Stem Cell Therapy And Research
US: (800) 969-4188 | Mexico: (619) 866-6000 | India: +91-8905483753

Archives

Author's Posts

-->

Stem Cell Therapy for Liver Cirrhosis – Patient Testimonial

 

 

Mr. Pranav Parekh is yet another sufferer of liver cirrhosis; who has acknowledged the science of regenerative medicine and trusted GIOSTAR to offer him stem cells therapy. The patient has had severely progressed liver cirrhosis, which was confirmed through liver biopsy, after his consultation with gastroenterologist. The patient underwent three sessions of stem cells infusion and found drastic improvement in his pathological reports; confirming his recovery.

Hello, my name is Pranav Parekh, 32 years old from Valsad. I am a working professional and was suffering with swellings in my legs and hands for quite a long time. Initially, I ignored it to be a normal swelling, but later on I could sense the severity of the disease; when I noticed unusual fluid accumulation in my legs, abdominal pain, loss of appetite and vomiting like sensations. These symptoms forced me to visit specialists, who suggested me liver biopsy along with 2-3 other diagnostic tests. Finally, on October 2015, I confirmed with Liver Cirrhosis, and my doctor suggested me liver transplant, as an ultimate treatment option.

I was very disappointed and frustrated with my chronic ailment and desperately finding a solution for the said problem. I started searching for a suitable liver donor; but it was checking my patience level, as I was not able to find a suitable donor. My desperation, ultimately allowed me to consult GIOSTAR, stem cells experts.

I understood the procedure and principle thoroughly; and decided to undergo treatment as my preferred choice. I underwent three sessions of stem cells therapy and during each session, I found tremendous improvement in my stamina, emotional wellbeing and physical wellbeing. After 3rd session, I found that my swelling has disappeared completely and my other symptoms, like frequent fever, chills, etc. were as well observed to be under control. Now, I don’t have to live with a fear of any time hospitalization and very happy with the treatment outcome.

My reports have confirmed that my haemoglobin has increased from 9 initially to 11.1, whereas total bilirubin has gone down from 8. 8 to 8.1. The most important parameter suggesting better recovery is albumin, which has found to be increased from 2.8 to 3.1.

-->

Cancer Cells Immunotherapy – Patient Testimonial

 

 

My name is Bharat Bhai Shah and I am 67 years old. I was suffering from recurrent ulcerations that used to get relieved with topical applications of antibiotics; only to happen again! I had a constant pain around those patches of my cheek, but ignored it for quite some time. Almost 2-3 months ago, I had been for my dental checks; where I was warned for the doubtful ulceration around my left cheek! As I was tired of repeated ulcerations and pain in my mouth; I decided to have a detailed consultation with the specialist at GIOSTAR.

I found the staff and experts very knowledgeable, humble and friendly. I had consultation with an expert and was advised to undergo biopsy check on 4th July; which turned out to be a buccal mucosa. As a matter of fact, I had been offered three sessions of Cancer Immunotherapy, with an interval of 15 days; after each infusion.

Accordingly, the first session of treatment was scheduled on 29th July. It was just a one day matter and I was discharged on the same day. Initially I was worried about the treatment outcome and effectiveness, as I felt pain around my teeth after first session of infusion. I experienced almost 50% pain reduction after second round of infusion and this definitely strengthened my confidence. I was feeling improvement internally. I strictly followed my diet chart. I did not experience any sort of problem, such as loss of appetite, loss of weight.

After my third session i.e. on 26th August, I am living completely painless life without any diet restriction. I would definitely recommend this treatment to other Cancer sufferer.

 

 

Note: Result varies from patient to patient. These testimonials do not constitute typical results nor do we claim otherwise.

 

Editorial Board Membership of Journal of Embryology & Developmental Biology

 

Dear Dr. Srivastava,

It is a pleasure to welcome you to the Editorial Board. Attached is the confirmation letter for your record. We would like to request you to send us your CV for our record. We also updated your information on the journal webpage at following link:

https://www.jscimedcentral.com/Development/editors.php

Once we receive any manuscript in your area of expertise, we will send you a request for editorial handling and review. We greatly appreciate any contributions or feedback.

Please do not hesitate to contact us if you have any questions.

Best regards,

Kana

—–

Kanako Nishino – Publishing Assistant
Editorial Office – Journal of Embryology & Developmental Biology

JSciMed Central, 1455 Frazee Road, Suite 500 (Office 570), San Diego, California 92108, USA
Direct Tel: 1-619-940-8643

Toll free number: 1-888-572-4633 (1-888-JSCIMED)

Fax: 1-844-572-4633 (1-844-JSCIMED)
Email: Kanako.Nishino@jscimedcentral.com

Journal: http://www.jscimedcentral.com/Development/

Journal Email: development@jscimedcentral.com

Website: www.jscimedcentral.com

 

Special Issue: “Cytoprotective Mediators and Signaling Pathways in Cardiovascular Stem Cell Therapy”

Dear Dr. Srivastava,

We are currently accepting submissions for our upcoming Special Issue titled “Cytoprotective Mediators and Signaling Pathways in Cardiovascular Stem Cell Therapy,” which will be published in Stem Cells International in January 2017. The Special Issue is open to both original research articles and review articles, and the deadline for submission is August 19, 2016. You can find the Call for Papers at http://www.hindawi.com/journals/sci/si/353148/cfp/.

The most recent Impact Factor for Stem Cells International is 3.687 according to Thomson Reuters’ latest Journal Citation Reports. The journal is a peer-reviewed, open-access publication, which means that all published articles are made freely available online at http://www.hindawi.com/journals/sci/ without a subscription and authors retain the copyright of their work. Moreover, all published articles will be made available on PubMed Central and indexed in PubMed at the time of publication.

Please read over the journal’s author guidelines at http://www.hindawi.com/journals/sci/guidelines/ for more information on the journal’s policies and the submission process. Manuscripts should be submitted online to the Special Issue at http://mts.hindawi.com/submit/journals/sci/psps/.
Please do not hesitate to contact me if you have any questions.

Best regards,
Adam Mohamed
——————————–
Adam Mohamed
Editorial Office
Stem Cells International
Hindawi Publishing Corporation
http://www.hindawi.com

Make An Enquiry

We are here to help you

WordPress Video Lightbox